VALERIE REAP: Open Payments
NPI 1104185594 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $29 |
| UCB, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| SK Life Science, Inc. | 1 | $19 |
| ARGENX US, INC. | 1 | $14 |
Products named: Rystiggo, QUTENZA, Ocrevus Zunovo, NURTEC ODT, QULIPTA, VYALEV, VYVGART HYTRULO.
Industry payments across NY — which companies pay providers there.
